Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 33 P11 | DOI: 10.1530/endoabs.33.P11

BSPED2013 Poster Presentations (1) (89 abstracts)

Succesfully modified intermittent i.v. calcium treatment in a patient with hereditary vitamin D resistant rickets with alopecia: presence of nonsense mutation in ligand binding domain of vitamin D receptor

Betul Ersoy 1 , Seniha Kiremitci 1 & Sachiko Kitanaka 2


1Celal Bayar University, School of Medicine, Manisa, Turkey; 2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.


Hereditary vitamin D-resistant rickets (HVDRR) is a rare recessive genetic disorder caused by mutations in the VDR that result in end organ resistance to 1,25-(OH)2D3 action. Here, we describe a patient with HVDDR with severe alopecia and rickets. Patient was 3 years old male presenting with gait disorder. He had hypocalcemia (8 mg/dl), secondary hyperparathyroidism (1232 pg/ml), and elevated serum alkaline phosphatase (661 U/l) and 1,25-dihydroxyvitamin D3 (>250 pg/ml). DNA sequence analyses of the vitamin D receptor (VDR) gene of ligand binding domain (LBD) showed that the patient had homozygous mutation for Q152X at exon five. This mutation was a C to T transition resulting in a premature stop at codon 152. Although his parents were non-consanguineous, both of his parents were found to be heterozygous for the mutation. The patient was initially treated with calcitriol (80 ng/kg per day) and high dose oral calcium (150 mg/kg per day) for 1 year. At the end of the first year, intermittent i.v. calcium therapy (5 days/month) was started, because of insufficient clinical and radiological improvement. After 2 years from intermittent i.v. calcium therapy, there was a clear clinical improvement based on clinical and X-ray findings as well as permenant improvement in biochemical findings. However, alopecia in our patient remained unchanged, despite treatment and improvement of rickets. We report the case of HVDRR with a mutation in the LBD and severe alopecia that was successfully treated with intermittent (5 days/month) i.v. calcium treatment.